Impact of Web Application Support Versus Standard Management on Compliance With Adjuvant Hormone Therapy at 18 Months in Patients Treated for Breast Cancer

Launched by CENTRE FRANCOIS BACLESSE · Sep 17, 2020

Keywords

ClinConnect Summary

This clinical trial is looking at how a special web application can help women with breast cancer stick to their hormone therapy treatment over 18 months. Hormone therapy is an important treatment that can help prevent cancer from coming back after surgery. The researchers believe that using this web app will make it easier for patients to follow their treatment plan and improve their quality of life.

To join this study, participants need to be women over 18 years old who are starting hormone therapy for breast cancer and can speak French. They should have access to a smartphone or computer and the internet. If qualified, participants will be asked to use the web application alongside their usual care. This study is currently recruiting, so there’s an opportunity for eligible women to contribute to important research that could benefit future patients.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Patient \> 18 years old
• • Breast cancer patient candidate for adjuvant hormone therapy
• • Mastery of the French language
• • Patient with a cell phone and an Internet connection
• • Patient able to use a computer, smartphone, or tablet.
• • Patient affiliated to a social security system
• • Signing of informed consent prior to any specific study-related procedure
• Exclusion Criteria:
• • Patient who has previously received hormone therapy for cancer.
• • Patient not trained in the use of the application
• • Any associated medical or psychiatric condition that might compromise the patient's ability to participate in the study
• • Patients with locoregional or metastatic recurrence
• • Other history of cancer.
• • Patient deprived of liberty, under guardianship or curatorship
• • Simultaneous participation in a therapeutic clinical trial or other clinical study involving a connected tool
• • Patient unable to undergo trial follow-up for geographical, social or psychopathological reasons